How is cardiac power output calculated using mean arterial pressure and cardiac output, what is the normal range, and what cutoff indicates cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Power Output Formula and Clinical Thresholds

Cardiac power output is calculated as (cardiac output in L/min × mean arterial pressure in mmHg) ÷ 451, yielding a value in watts; normal resting CPO ranges from approximately 0.9 to 1.1 W, and a CPO < 0.6 W defines refractory cardiogenic shock requiring mechanical circulatory support. 1, 2

Formula and Calculation

The standard formula is:

  • CPO (watts) = [Cardiac Output (L/min) × Mean Arterial Pressure (mmHg)] ÷ 451 1

This calculation couples both the flow domain (cardiac output) and pressure domain (mean arterial pressure) of the cardiovascular system, providing an integrative measure of cardiac pumping capability that surpasses either parameter alone. 1

Alternative formula incorporating right atrial pressure:

  • CPO-RAP (watts) = [(MAP - RAP) × CO] ÷ 451 3

This modified formula may enhance prognostic accuracy in patients with elevated right atrial pressure (>8 mmHg), as it accounts for the true pressure gradient driving systemic perfusion. 3

Normal Reference Values

Resting cardiac power output in healthy adults:

  • Normal range: 0.9–1.1 W 4
  • Athletes and sedentary individuals demonstrate similar resting CPO values (1.08 ± 0.2 W vs 1.1 ± 0.24 W). 4

Peak exercise cardiac power output:

  • Athletes achieve higher peak CPO (5.87 ± 0.75 W) compared to non-athletes (5.4 ± 0.69 W), reflecting superior cardiac reserve. 4

Critical Thresholds for Cardiogenic Shock

CPO < 0.6 W is the single most critical hemodynamic threshold for identifying refractory cardiogenic shock and predicting mortality. 2, 5

This cutoff:

  • Defines refractory shock requiring escalation to mechanical circulatory support 2
  • Outperforms cardiac index, cardiac output, mean arterial pressure, and all other hemodynamic parameters as a predictor of in-hospital mortality 5
  • Remains the strongest independent correlate of death even after adjusting for age and comorbidities 5

Additional prognostic thresholds:

  • CPO ≤ 0.53 W: Associated with 49% in-hospital mortality versus 20% mortality when CPO > 0.53 W in acute cardiac disease 6
  • CPO < 0.6 W combined with PAPi < 1.0: Constitutes a clear indication for mechanical circulatory support consideration 7, 2

Clinical Application Algorithm

When evaluating a patient with suspected cardiogenic shock:

  1. Obtain invasive hemodynamics via pulmonary artery catheter:

    • Measure cardiac output (thermodilution or Fick method) 1
    • Record mean arterial pressure simultaneously 1
    • Document right atrial pressure if elevated RAP suspected 3
  2. Calculate CPO using the standard formula 1

  3. Interpret CPO in context of shock phenotype:

    • CPO < 0.6 W + PCWP > 15 mmHg + RA < 15 mmHg: Left-ventricular-dominant refractory shock 2
    • CPO < 0.6 W + RA > 15 mmHg + PCWP < 15 mmHg: Right-ventricular-dominant refractory shock 2
    • CPO < 0.6 W + RA > 15 mmHg + PCWP > 15 mmHg: Biventricular refractory shock 2
  4. Assess for contraindications to mechanical support:

    • Anoxic brain injury, irreversible end-organ failure, prohibitive vascular access, or DNR status 2
  5. Escalate to mechanical circulatory support if CPO < 0.6 W persists despite maximal medical therapy (two vasoactive medications at adequate doses plus treatment of underlying etiology). 2

Critical Pitfalls and Caveats

CPO is superior to cardiac output alone for prognostication. When both CPO and cardiac output were analyzed simultaneously in multivariate models, CPO remained strongly associated with mortality (OR 0.63, P = 0.01) while cardiac output did not (OR 1.05, P = 0.78). 6 This demonstrates that pressure-generating capacity matters as much as flow.

Age and sex influence CPO values. Increasing age correlates inversely with cardiac power index (r = -0.334, P < 0.001), and women demonstrate lower cardiac power index than men (0.29 ± 0.11 vs 0.35 ± 0.15 W/m², P = 0.005) even after age adjustment. 5 However, the < 0.6 W threshold for refractory shock applies universally.

Consider CPO-RAP in patients with elevated right atrial pressure. When RAP exceeds 8 mmHg, incorporating RAP into the formula [(MAP - RAP) × CO ÷ 451] significantly improves prognostic discrimination (81% vs 63% event-free survival, P = 0.01), whereas standard CPO shows no significant difference (76% vs 64%, P = 0.08). 3

Do not delay urgent revascularization to obtain CPO measurements. While CPO provides critical prognostic information, immediate coronary angiography takes precedence in acute myocardial infarction with cardiogenic shock. 2 Obtain hemodynamics once the patient is stabilized in the catheterization laboratory or intensive care unit.

Severe tricuspid regurgitation invalidates thermodilution-derived CPO. Use the Fick method for cardiac output measurement in this setting to ensure accuracy. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Cardiogenic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiac power output and its response to exercise in athletes and non-athletes.

Clinical physiology and functional imaging, 2013

Guideline

Pulmonary Artery Pulsatility Index (PAPi) – Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.